Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
A customer complaint was received for therascreen: k-ras mutation kit lot dk 262-01 which confirmed a labelling error with taq polymerase one of the components packaged within the kit. the therascreen: k-ras mutation kit lot dk 262-01 is correctly labelled with an expiration date of 27 april 2011 however the taq polymerase (taq) packaged within the kit is incorrectly labelled with an expiration date of 28 february 2011.